Cardinal Health’s profit margin lags behind peers, impacting growth. See why CAH stock’s outlook may be hindered by legal ...
The Dublin healthcare giant reported $226.8 billion in sales for FY24 that ended June 30, the ninth consecutive year of ...
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...
Cardinal Health is spending $3.9 billion ... $1.1 billion to buy Advanced Diabetes Supply Group, a diabetic medical supplies ...
The most recent trading session ended with Cardinal Health (CAH) standing at $122.53, reflecting a +0.93% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily gain of ...
About Cardinal Health, Inc. and Fresenius Medical Care AG Cardinal Health ... It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer ...